VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-00805 Package ID: USCOURTS-cofc-1_18-vv-00805 Petitioner: Matthew Hussong Filed: 2018-06-06 Decided: 2020-05-18 Vaccine: influenza Vaccination date: 2015-11-18 Condition: Guillain-Barre Syndrome (“GBS”) and chronic inflammatory demyelinating polyneuropathy (“CIDP”) Outcome: compensated Award amount USD: 175500 AI-assisted case summary: Matthew Hussong filed a petition for compensation under the National Vaccine Injury Compensation Program on June 6, 2018. He alleged that he developed Guillain-Barre Syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) after receiving an influenza vaccine on November 18, 2015. The respondent, the Secretary of Health and Human Services, denied that Mr. Hussong sustained a GBS Table injury, denied that the vaccine caused or significantly aggravated his alleged injuries, and denied that his current disabilities were the result of a vaccine-related injury. Despite these denials, the parties reached a settlement. On April 21, 2020, they filed a joint stipulation agreeing to settle the case. Special Master Mindy Michaels Roth adopted the stipulation. The settlement included a lump sum payment of $175,500.00, consisting of $130,000.00 for past and future pain and suffering, $35,000.00 for past lost earnings, and $10,500.00 for unreimbursed expenses. This payment was to be made via check payable to Matthew Hussong. The decision noted that the case was originally filed on April 21, 2020, and the decision was issued on May 18, 2020. Petitioner was represented by Jessica Olins, Esq., and respondent was represented by Darryl Wishard, Esq. The public decision is unpublished but available online, with provisions for redaction of confidential information. Theory of causation field: Matthew Hussong filed a petition on June 6, 2018, alleging GBS and CIDP after receiving an influenza vaccine on November 18, 2015. The respondent denied a Table injury, causation, and aggravation. The parties stipulated to settle the case, with the respondent agreeing to pay $175,500.00, comprising $130,000.00 for pain and suffering, $35,000.00 for past lost earnings, and $10,500.00 for unreimbursed expenses. Special Master Mindy Michaels Roth adopted the stipulation on May 18, 2020. The stipulation stated that the case involved an influenza vaccine listed in the Vaccine Injury Table and that petitioner alleged symptoms lasting more than six months. The stipulation did not detail specific medical experts, clinical findings, or a precise mechanism of injury, but it represented a negotiated settlement of liability and damages. Petitioner was represented by Jessica Olins, Esq., and respondent by Darryl Wishard, Esq. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_18-vv-00805-0 Date issued/filed: 2020-05-18 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 4/21/2020) regarding 42 DECISION Stipulation/Proffer. Signed by Special Master Mindy Michaels Roth. (mw) Service on parties made. -------------------------------------------------------------------------------- Case 1:18-vv-00805-UNJ Document 50 Filed 05/18/20 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-805V Filed: April 21, 2020 * * * * * * * * * * * * * MATTHEW HUSSONG, * UNPUBLISHED * Petitioner, * Decision on Joint Stipulation; * Guillain-Barre Syndrome v. * (“GBS”); Chronic * Inflammatory Demyelinating SECRETARY OF HEALTH * Polyneuropathy (“CIDP”); AND HUMAN SERVICES, * Influenza (“Flu”) Vaccine * Respondent. * * * * * * * * * * * * * * Jessica Olins, Esq., Maglio Christopher & Toale, Seattle, WA, for petitioner. Darryl Wishard, Esq., US Department of Justice, Washington, DC, for respondent. DECISION ON JOINT STIPULATION1 Roth, Special Master: On June 6, 2018, Matthew Hussong [“Mr. Hussong” or “petitioner”] filed a petition for compensation under the National Vaccine Injury Compensation Program.2 Petitioner alleges that he developed Guillain-Barre Syndrome (“GBS”) and chronic inflammatory demyelinating polyneuropathy (“CIDP”) after receiving an influenza (“flu”) vaccination on November 18, 2015. Stipulation, filed Apr. 21, 2020, at ¶¶ 1-4. Respondent denies that petitioner sustained a GBS Table injury; denies that the vaccine caused or significantly aggravated petitioner’s alleged injuries or any other injury; and denies that petitioner’s current disabilities are the result of a vaccine-related injury. Stipulation at ¶ 6. 1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107- 347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will be available to anyone with access to the internet. However, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:18-vv-00805-UNJ Document 50 Filed 05/18/20 Page 2 of 7 Nevertheless, the parties have agreed to settle the case. On April 21, 2020, the parties filed a joint stipulation agreeing to settle this case and describing the settlement terms. Respondent agrees to issue the following payment: A lump sum of $175,500.00 (consisting of $130,000.00 for past and future pain and suffering; $35,000.00 for past lost earnings; and $10,500.00 for unreimbursed expenses) in the form of a check payable to petitioner, Matthew Hussong. This amount represents compensation for all damages that would be available under § 300aa-15(a). I adopt the parties’ stipulation attached hereto, and award compensation in the amount and on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/ Mindy Michaels Roth Mindy Michaels Roth Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice renouncing the right to seek review. 2 Case 1:18-vv-00805-UNJ Document 50 Filed 05/18/20 Page 3 of 7 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS ___________________________________ ) MATTHEW HUSSONG, ) ) Petitioner, ) No. 18-805V ECF ) v. ) Special Master Roth ) SECRETARY OF HEALTH ) AND HUMAN SERVICES, ) ) Respondent. ) ___________________________________ ) STIPULATION The parties hereby stipulate to the following matters: 1. Petitioner, Matthew Hussong, filed a petition for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to 34 (the “Vaccine Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt of the influenza (“flu”) vaccine, which is contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3(a). 2. On November 18, 2015, petitioner received the flu vaccine. 3. The vaccine was administered within the United States. 4. Petitioner alleges that, as a result of receiving the vaccine, he suffered from alleged injuries of Guillain-Barre syndrome (“GBS”) and chronic inflammatory demyelinating polyneuropathy (“CIDP”), and that he experienced symptoms of these injuries for more than six months. 5. Petitioner represents that there has been no prior award or settlement of a civil action 1 Case 1:18-vv-00805-UNJ Document 50 Filed 05/18/20 Page 4 of 7 for damages as a result of his alleged injuries. 6. Respondent denies that petitioner sustained a GBS Table injury; denies that the vaccine caused or significantly aggravated petitioner’s alleged injuries or any other injury; and, denies that petitioner’s current disabilities are the result of a vaccine-related injury. 7. Maintaining their above-stated positions, the parties nevertheless now agree that the issues between them shall be settled and that a decision should be entered awarding the compensation described in paragraph 8 of this Stipulation. 8. As soon as practicable after an entry of judgment reflecting a decision consistent with the terms of this Stipulation, and after petitioner has filed an election to receive compensation pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue the following vaccine compensation payment: A lump sum of $175,500.00 (consisting of $130,000.00 for past and future pain and suffering; $35,000.00 for past lost earnings; and, $10,500.00 for unreimbursed expenses), in the form of a check payable to petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). 9. As soon as practicable after the entry of judgment on entitlement in this case, and after petitioner has filed both a proper and timely election to receive compensation pursuant to 42 U.S.C. Section 300aa-21(a)(1), and an application, the parties will submit to further proceedings before the special master to award reasonable attorneys’ fees and costs incurred in proceeding upon this petition. 10. Petitioner and his attorney represent that compensation to be provided pursuant to this Stipulation is not for any items or services for which the Program is not primarily liable 2 Case 1:18-vv-00805-UNJ Document 50 Filed 05/18/20 Page 5 of 7 under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can reasonably be expected to be made under any State compensation programs, insurance policies, Federal or State health benefits programs (other than Title XIX of the Social Security Act (42 U.S.C. §1396 et seq.)), or by entities that provide health services on a pre-paid basis. 11. Payment made pursuant to paragraph 8 of this Stipulation, and any amounts awarded pursuant to paragraph 9 of this Stipulation, will be made in accordance with 42 U.S.C. §300aa-15(i), subject to the availability of sufficient statutory funds. 12. The parties and their attorneys further agree and stipulate that, except for any award for attorneys’ fees and litigation costs, and past unreimbursed expenses, the money provided pursuant to this Stipulation will be used solely for the benefit of petitioner, as contemplated by a strict construction of 42 U.S.C. § 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C. §§ 300aa-15(g) and (h). 13. In return for the payments described in paragraphs 8 and 9, petitioner, in his individual capacity and on behalf of his heirs, executors, administrators, successors or assigns, does forever irrevocably and unconditionally release, acquit and discharge the United States and the Secretary of Health and Human Services from any and all actions, causes of action (including agreements, judgments, claims, damages, loss of services, expenses and all demands of whatever kind or nature) that have been brought, could have been brought, or could be timely brought in the Court of Federal Claims, under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 et seq., on account of, or in any way growing out of, any and all known or unknown, suspected or unsuspected personal injuries to or death of petitioner resulting from, or alleged to have resulted from, the vaccine administered on November 18, 2015, as alleged by 3 Case 1:18-vv-00805-UNJ Document 50 Filed 05/18/20 Page 6 of 7 petitioner in a petition for vaccine compensation filed on or about June 6, 2018, in the United States Court of Federal Claims as petition No. 18-805V. 14. If petitioner should die prior to entry of judgment, this agreement shall be voidable upon proper notice to the Court on behalf of either or both of the parties. 15. If the special master fails to issue a decision in complete conformity with the terms of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a decision that is in complete conformity with the terms of this Stipulation, then the parties’ settlement and this Stipulation shall be voidable at the sole discretion of either party. 16. This Stipulation expresses a full and complete negotiated settlement of liability and damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the parties hereto to make any payment or to do any act or thing other than is herein expressly stated and clearly agreed to. The parties further agree and understand that the award described in this stipulation may reflect a compromise of the parties’ respective positions as to liability and/or amount of damages, and further, that a change in the nature of the injury or condition or in the items of compensation sought, is not grounds to modify or revise this agreement. 17. This Stipulation shall not be construed as an admission by the United States or the Secretary of Health and Human Services that petitioner sustained a Table injury, or that the vaccine either caused or significantly aggravated petitioner’s alleged injury or any other injury. 18. All rights and obligations of petitioner hereunder shall apply equally to petitioner’s heirs, executors, administrators, successors, and/or assigns. END OF STIPULATION 4 Case 1:18-vv-00805-UNJ Document 50 Filed 05/18/20 Page 7 of 7